Velocity Financial announces dual listing on new Texas stock exchange
Westlake Village-based Velocity Financial, a leader in investor real estate loans, announced Aug. 13 that it will be one of the founding members of the new electronic equities exchange, NYSE Texas. Its common stock will be dual listed on the new exchange, headquartered in Dallas. Velocity will maintain its primary listing on the New York Read More →
MannKind inks $500M financing agreement with Blackstone
Westlake Village-based MannKind Corporation is receiving some extra help to advance some of its short and long-term growth strategies. Announced Aug. 6, MannKind, a biotech company focused on inhaled therapeutic products, entered into a financing agreement worth up to $500 million with Blackstone, the world’s largest alternative asset manager, with more than $1 trillion in Read More →
Amgen earnings strong, stock dips as investors await MariTide news
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Gallegly seeks dismissal of lawsuit against CLU
A motion to dismiss the 2021 breach of contract lawsuit against California Lutheran University and former presidents Chris Kimball and Lori Varlotta has been filed Ventura County Superior Court, by attorneys for former Congressman Elton Gallegly (R-Simi Valley). The filing could be a precursor to a settlement in the case, a stated goal of CLU Read More →
Loan secured to help refinance Simi Valley retail center
The Civic Center Plaza retail center, a 145,000-square-foot property sitting on 11.5 acres, in Simi Valley has secured a $26.05 million loan to refinance its maturing debt. Secured by Gantry, the largest independent commercial mortgage banking firm in the U.S., and announced July 31, the retail center offers nearly 1,000 parking spaces and is home Read More →
Atara shares up behind the FDA’s priority review of Ebvallo
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
